The liver in rheumatic diseases

Seminars in Arthritis and Rheumatism

Volumn 11, Issue 4, 1982, Pages 399-405

  Weinblatt, Michael E ^a   Tesser, John R P ^a   Gilliam III, John H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIINFLAMMATORY AGENT; AUROTHIOMALATE; FENOPROFEN; GOLD SALT; IBUFENAC; IBUPROFEN; NAPROXEN; PENICILLAMINE; PHENYLBUTAZONE; SALICYLATE SODIUM;

ADVERSE DRUG REACTION; DRUG INDUCED DISEASE; DRUG THERAPY; FELTY SYNDROME; HUMAN; INTOXICATION; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT; JUVENILE RHEUMATOID ARTHRITIS; LIVER; LIVER DISEASE; LIVER TOXICITY; MUSCLE; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY; VASCULITIS;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CRYOGLOBULINEMIA; FELTY'S SYNDROME; HEPATITIS, TOXIC; HUMAN; LIVER DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMYALGIA RHEUMATICA; RHEUMATIC DISEASES; RHEUMATIC FEVER; SALICYLATES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; TEMPORAL ARTERITIS; VASCULITIS;

EID: 0020447305     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(82)90027-0     Document Type: Article

References (77)

1. On a form of chronic joint disease in children
2. The advantages of hepatic injury and jaundice in certain conditions, notably the rheumatic diseases
3. Effect of jaundice on chronic infectious (atrophic) arthritis and on primary fibrositis Further observations attempts to reproduce the phenomenon
4. Therapeutic effect of induced jaundice in rheumatoid arthritis
5. Raised serum alkaline phosphatase in rheumatoid disease: An index of liver dysfunction
6. Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis
7. Gamma glutamyl transpeptidase levels in arthritis: A correlation with clinical and laboratory indices of disease activity
8. The liver in rheumatoid arthritis
9. Morphological changes in liver biopsies from patients with rheumatoid arthritis
10. Liver in Felty's Syndrome
11. Felty's syndrome: Clinical and serological analysis of 34 cases
12. Esophagel varices in Felty's syndrome: A case report and review of the literature
13. Nodular regenerative hyperplasia of the liver in Felty's syndrome
14. Hepatic involvement in juvenile rheumatoid arthritis
15. Acute hepatic dysfunction in juvenile rheumatoid arthritis
16. Hepatic abnormalities in adult onset Still's disease
17. Fifteen palients with adult onset Still's disease: Life-threatening liver failure in two
18. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases
19. Apparent hepatic dysfunction in lupus erythematosus
20. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus
21. Spontaneous rupture of the liver: An unusual complication of SLE
22. The spectrum of liver disease in systemic lupus erythematosus Report of 33 histologically-proved cases and review of the literature
23. “Lupoid” hepatitis, a nonentity in the spectrum of chronic active liver disease
24. Diagnostic troubles connected with differentiation of systemic lupus erythematosus against chronic active hepatitis
25. Chronic disease of the liver associated with systemic scleroderma
26. Rheumatic disorders in primary biliary cirrhosis
27. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia
28. Corneal changes in a case of hepatitis
29. Liver disease in rheumatoid arthritis and Sjogren's syndrome: Prospective study using biochemical and seriological markers of hepatic dysfunction
30. Liver disease in Sjogren's Syndrome and rheumatoid arthritis
31. Sjögren's Syndrome
32. Multisystem involvement in chronic liver disease: Studies on the incidence and pathogenesis
33. Polymyalgia rheumatica
34. Systemic giant cell arteritis with polymyalgia rheumatica
35. Liver involvement in polymyalgia rheumatica
36. Polymyalgia rheumatica and liver disease
37. Granulomatous liver disease and giant cell arteritis: Case report and literature review
38. Liver involvement in the syndrome of mixed cryoglobulinemia
39. Association between hepatitis B virus and essential mixed cryoglobulinemia
40. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection
41. Cryoglobulins in acute and chronic liver diseases
42. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes
43. Circulating immune complexes and complement activation in primary biliary cirrhosis
44. The clinical manifestations of essential polyangiitis (periarteritis nodosa) with emphasis on the hepatic manifestations
45. Polyarthritis, polyarteritis and hepatitis B
46. Association between polyarteritis and Australia antigen
47. Viruses and the connective tissue diseases
48. Small vessel vasculitis caused by hepatitis B virus immune complexes
49. Effect of aspirin administration of serum glutamic oxaloacetic and glutamic pyruvic transaminases in children
50. Effects of salicylate on liver enzymes in normal young adults
51. Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers
52. Evaluation in man of fenclozic acid (I.C.I. 54,450:Myalex), a new anti-inflammatory agent
53. Salicylate hepatitis
54. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis
55. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis: A prospective study
56. Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis
57. Hepatotoxicity with encephalopathy associated with aspirin therapy in rheumatoid arthritis
58. Chronic salicylate administration in juvenile rheumatoid arthritis: Aspirin “hepatitis” and its clinical significance
59. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus
60. Serum transaminases and salicylate therapy
61. Salicylate hepatotoxicity in Reiter's syndrome
62. Serum transaminases during salicylate therapy
63. Ibufenac (4-isobutylphenyl acetic acid)
64. Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity
65. Ibuprofen hypersensitivity in systemic lupus erythematosus
66. Jaundice associated with naproxen (Letter)
67. Fenoprofen-induced hepatotoxicity (Letter)
68. Fatal hepatitis probably due to indomethacin
69. Sudden death in arthritic children receiving large doses of indomethacin
70. Sulindac (clinoril) hepatitis
71. Phenylbutazone and hepatitis
72. Intrahepatic cholestasis due to therapy of rheumatoid arthritis
73. Hepatic toxicity associated with therapy
74. Cholestasis associated with D-penicillamine therapy: Case report and review of the literature
75. Allopurinol hepatotoxicity. Case report and literature review
76. Massive hepatic necrosis in a patient receiving allopurinol